A spectrophotometric quantitation of cytotoxic action of antiserum and complement by trypan blue

Por Saijo, N.
Publicado em 1973

Progress in treatment of small-cell lung cancer: role of CPT-11

Por Saijo, N
Publicado em 2003

Recovery of the accumulation ability of thiomethyl-beta-galactoside in Escherichia coli after bacteriophage T4 infection.

Por Saijo, N, Okamoto, K
Publicado em 1976

Reply to ‘Malignant pericardial effusion: sclerotherapy or local chemotherapy?’

Por Kunitoh, H, Tamura, T, Saijo, N
Publicado em 2009

Emerging ethnic differences in lung cancer therapy

Por Sekine, I, Yamamoto, N, Nishio, K, Saijo, N
Publicado em 2008

Characterisation of a vindesine-resistant human small-cell lung cancer cell line.

Por Ohta, S., Nishio, K., Kubo, S., Nishio, M., Ohmori, T., Takahashi, T., Saijo, N.
Publicado em 1993

Effects of BCG and 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) on the cytostatic activity of macrophages in normal and tumour-bea...

Por Saijo, N., Irimajiri, N., Ozaki, A., Shimizu, E., Niitani, H.
Publicado em 1980

Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion.

Por Kunitoh, H., Saijo, N., Furuse, K., Noda, K., Ogawa, M.
Publicado em 1998

Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.

Por Sugimoto, Y., Ohe, Y., Nishio, K., Ohmori, T., Morikage, T., Fujiwara, Y., Saijo, N.
Publicado em 1992

Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer [seecomments]

Por Yokoyama, A., Kurita, Y., Saijo, N., Tamura, T., Noda, K., Shimokata, K., Matsuda, T.
Publicado em 1998

Phospholipase C-mediated hydrolysis of phosphatidylcholine is activated by cis-diamminedichloroplatinum(II).

Por Nishio, K, Sugimoto, Y, Fujiwara, Y, Ohmori, T, Morikage, T, Takeda, Y, Ohata, M, Saijo, N
Publicado em 1992

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation

Por Fujisaka, Y, Sugiyama, T, Saito, H, Nagase, S, Kudoh, S, Endo, M, Sakai, H, Ohashi, Y, Saijo, N
Publicado em 2011

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer:...

Por Okamoto, H, Watanabe, K, Kunikane, H, Yokoyama, A, Kudoh, S, Asakawa, T, Shibata, T, Kunitoh, H, Tamura, T, Saijo, N
Publicado em 2007

Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma

Por Sekine, I, Nokihara, H, Horiike, A, Yamamoto, N, Kunitoh, H, Ohe, Y, Tamura, T, Kodama, T, Saijo, N
Publicado em 2004

Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.

Por Nishio, K., Sugimoto, Y., Nakagawa, K., Niimi, S., Fujiwara, Y., Bungo, M., Kasahara, K., Fujiki, H., Saijo, N.
Publicado em 1990

Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes.

Por Niimi, S., Nakagawa, K., Yokota, J., Tsunokawa, Y., Nishio, K., Terashima, Y., Shibuya, M., Terada, M., Saijo, N.
Publicado em 1991

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)

Por Kunitoh, H, Tamura, T, Shibata, T, Imai, M, Nishiwaki, Y, Nishio, M, Yokoyama, A, Watanabe, K, Noda, K, Saijo, N
Publicado em 2009

A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605)

Por Kunitoh, H, Tamura, T, Shibata, T, Nakagawa, K, Takeda, K, Nishiwaki, Y, Osaki, Y, Noda, K, Yokoyama, A, Saijo, N
Publicado em 2009

Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.

Por Saijo, N., Shimizu, E., Shibuya, M., Irimajiri, N., Takizawa, T., Eguchi, K., Shinkai, T., Tominaga, K., Shimabukuro, Z., Taniguchi, T., Hoshi, A.
Publicado em 1982

Anti-tumour activities of a new benzo[c]phenanthridine agent, 2,3-(methylenedioxy)-5-methyl-7-hydroxy-8-methoxybenzo[c]phena nthridini um hydrogensulphate dihydrate (NK109), agains...

Por Kanzawa, F., Nishio, K., Ishida, T., Fukuda, M., Kurokawa, H., Fukumoto, H., Nomoto, Y., Fukuoka, K., Bojanowski, K., Saijo, N.
Publicado em 1997